Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Expands Opportunities for 1906 Edibles
- LXRP has expanded its cannabis product relationship with Nuka Enterprises’ 1906 brand
- DehydraTECH enables 1906 chocolates to deliver on both function and flavor
- The company is expecting a tenfold increase in sales with expansion to legal markets
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), the developer and out-licenser for the disruptive and cost-effective DehydraTECH, recently announced that it has expanded its cannabis product relationship with Nuka Enterprises LLC, maker of 1906 cannabis edibles for high-functioning adults (http://nnw.fm/UzUV1).
Since its beginnings in 2016, 1906 chocolates have benefited from DehydraTECH technology. In three short years, Nuka has become Colorado’s fastest-growing edibles company, and 1906 chocolates are currently available in more than 200 dispensaries. The products have been highlighted in nationally recognized publications including Vogue, Penthouse, Cosmo and Huffington Post.
An article in Forbes (http://nnw.fm/n3udT) outlines the process that the 1906 team follows to create high-quality chocolates that deliver an intense, targeted experience. “Cannabis is great plant medicine, but the experience has been so disjointed,” 1906 co-founder Peter Barsoom stated in the article. “You’d have a quality, organic, good-tasting strain of cannabis being paired with mediocre chocolate with no idea of how it would make you feel — or when [the effects] would kick in.”
Using Lexaria’s DehydraTECH allows the 1906 brand to continue to deliver on both function and flavor, thus providing the consumer with a consistent experience.
The DehydraTECH drug-delivery platform improves speed, taste and delivery of bioactive compounds. Lexaria out-licenses this edible technology to companies such as Nuka Enterprises to enhance already-established, high-quality brands or create new ones.
DehydraTECH offers healthier alternatives to smoking for the consumption of bioactive substances. The technology delivers 475 percent more CBD in 15 minutes than other conventional industry formulations. Using this technology, the onset of effects can be experienced in 15 to 20 minutes rather than the unpredictable 60-to-120-minute window that’s traditionally required.
“As the fastest growing edibles brand in Colorado, we believe a huge part of our consumer appeal is because of this fast-acting technology,” Nuka Enterprises CEO and co-founder Peter Barsoom said in a news release. “We look forward to continuing to innovate alongside Lexaria, whose technology is the best in the industry.”
Over the next 18 months, Nuka is expecting an estimated tenfold increase in product volume as it expands to additional legal markets. The 1906 brand currently offers six distinct formulations of select cannabis strains with targeted plant medicines and high-quality chocolate. Nuka is expected to begin to develop consumer products containing CBD that will be available across the U.S. marketplace. In addition to its original chocolate products, Nuka has acquired rights to use DehydraTECH to expand its product options to include candies, beverages, capsules and pills and topical creams.
For more information, visit the company’s website at www.LexariaBioscience.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- LXRP has expanded its cannabis product relationship with Nuka Enterprises’ 1906 brand
- DehydraTECH enables 1906 chocolates to deliver on both function and flavor
- The company is expecting a tenfold increase in sales with expansion to legal markets
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), the developer and out-licenser for the disruptive and cost-effective DehydraTECH, recently announced that it has expanded its cannabis product relationship with Nuka Enterprises LLC, maker of 1906 cannabis edibles for high-functioning adults (http://nnw.fm/UzUV1).
Since its beginnings in 2016, 1906 chocolates have benefited from DehydraTECH technology. In three short years, Nuka has become Colorado’s fastest-growing edibles company, and 1906 chocolates are currently available in more than 200 dispensaries. The products have been highlighted in nationally recognized publications including Vogue, Penthouse, Cosmo and Huffington Post.
An article in Forbes (http://nnw.fm/n3udT) outlines the process that the 1906 team follows to create high-quality chocolates that deliver an intense, targeted experience. “Cannabis is great plant medicine, but the experience has been so disjointed,” 1906 co-founder Peter Barsoom stated in the article. “You’d have a quality, organic, good-tasting strain of cannabis being paired with mediocre chocolate with no idea of how it would make you feel — or when [the effects] would kick in.”
Using Lexaria’s DehydraTECH allows the 1906 brand to continue to deliver on both function and flavor, thus providing the consumer with a consistent experience.
The DehydraTECH drug-delivery platform improves speed, taste and delivery of bioactive compounds. Lexaria out-licenses this edible technology to companies such as Nuka Enterprises to enhance already-established, high-quality brands or create new ones.
DehydraTECH offers healthier alternatives to smoking for the consumption of bioactive substances. The technology delivers 475 percent more CBD in 15 minutes than other conventional industry formulations. Using this technology, the onset of effects can be experienced in 15 to 20 minutes rather than the unpredictable 60-to-120-minute window that’s traditionally required.
“As the fastest growing edibles brand in Colorado, we believe a huge part of our consumer appeal is because of this fast-acting technology,” Nuka Enterprises CEO and co-founder Peter Barsoom said in a news release. “We look forward to continuing to innovate alongside Lexaria, whose technology is the best in the industry.”
Over the next 18 months, Nuka is expecting an estimated tenfold increase in product volume as it expands to additional legal markets. The 1906 brand currently offers six distinct formulations of select cannabis strains with targeted plant medicines and high-quality chocolate. Nuka is expected to begin to develop consumer products containing CBD that will be available across the U.S. marketplace. In addition to its original chocolate products, Nuka has acquired rights to use DehydraTECH to expand its product options to include candies, beverages, capsules and pills and topical creams.
For more information, visit the company’s website at www.LexariaBioscience.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
